Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01412086 · ClinicalTrials.gov registry record
Inter-rater and Intra-rater Reliability of the Global Eyebrow Assessment Scale
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 112
- Enrollment target
NCT01412086: Completed study, sponsored by Allergan.
NCT01412086 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01412086 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 112 participants
- Enrollment target
Study Summary
This study evaluated the inter- and intra-rater reliability of the GEBA Scale with photonumeric guide for the assessment of overall eyebrow fullness. There is no treatment (intervention) associated with this study.
Primary Outcome
Inter-rater agreement (among raters) of the GEBA scores (1=very sparse, 2=sparse, 3=full, 4=very full) to assess eyebrow fullness was evaluated using Kendall's coefficient of concordance (Kendall's W). Each of 7 raters scored 112 subjects' eyebrows using the GEBA Scale at 2 different time points at day 1. The overall inter-rater agreement for Kendall's W for all raters combined was estimated based on the average of the scores from those 2 different time points. The degree of agreement of the poi
Interventions
- DRUG No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2011-08 |
| Est. Completion | 2011-09 |
What the finished NCT01412086 record still lists
NCT01412086 is an observational study that tracks outcomes without assigning an intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT01412086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01412086 about?
NCT01412086 is a clinical study titled "Inter-rater and Intra-rater Reliability of the Global Eyebrow Assessment Scale". This study evaluated the inter- and intra-rater reliability of the GEBA Scale with photonumeric guide for the assessment of overall eyebrow fullness. There is no treatment (intervention) associated with this study.
What is the current status of trial NCT01412086?
This trial is currently completed. The enrollment target is 112 participants. The study started on 2011-08. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01412086?
The interventions under investigation include: No Intervention (DRUG).
Who is sponsoring clinical trial NCT01412086?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia